Knee Arthroscopy for a Worn Meniscus: What the Sham Trials Revealed

For a worn, degenerative meniscus tear, keyhole surgery to trim the tear works no better than a fake operation. That is not a hunch or a cost-cutting opinion. It is what happened when surgeons ran the experiment properly, sending some patients to a real arthroscopic partial meniscectomy and others to a carefully staged placebo procedure, then measuring both groups a year later. Everyone got better, and the two groups got better by the same amount. The design that produced this answer, placebo surgery, is also one of the clearest teaching cases in all of clinical evidence.

Key points#

• A degenerative meniscus tear is age-related fraying, not the acute injury of a young athlete, and it often sits next to knee osteoarthritis that is the real pain source.
• In sham-controlled trials, arthroscopic partial meniscectomy for these tears produced no more relief than a placebo operation.
• Both surgery and sham patients improved, which is exactly why a control group was essential to tell a real drug from a convincing ritual.
• Long-term follow-up showed no advantage for surgery and a hint of faster radiographic joint wear.

Why this tear is so easy to blame#

The meniscus is a wedge of fibrocartilage that spreads load across the knee. When people picture a meniscus tear, they picture a footballer twisting and dropping to the turf. That acute injury is real, but it is not what these trials are about. A degenerative tear is the slow fraying that turns up on the scans of middle-aged and older adults, usually alongside the early stippling of osteoarthritis in the same joint.

Two facts about these tears make them a magnet for misplaced blame. First, they are almost a normal finding with age: large numbers of people who have never felt a twinge will show a frayed meniscus if you image them. Second, when someone does have knee pain and a tear appears on the MRI, the tear is frequently a bystander, and the surrounding arthritis is doing the hurting. So the setup writes itself. A patient hurts, a scan finds a tear, an operation trims it, and the knee feels better. The story is tidy, and it is also unreliable, because a second explanation fits every one of those facts just as well: the person would have improved anyway.

The hard part of testing a scalpel#

Pills are easy to fake. You match the shape and color, hand out sugar tablets to half the volunteers, and the comparison is clean. Surgery resists that trick, because the operation is wrapped in things that move symptoms on their own. Being taken seriously, going under anesthesia, being cared for, resting, and rehabilitating all push a patient toward feeling better, and so does simple expectation. On top of that, knee pain rises and falls in cycles, and people book surgery when they are at their worst, so some of the later improvement is just the natural drift back toward an average day.

To strip all of that away and isolate the trimming itself, investigators built a sham-surgery arm. Every participant entered the operating room, received anesthesia, and had the arthroscope inserted through the usual incisions. For a randomly chosen half, the surgeon then removed the damaged meniscal tissue. For the other half, the surgeon went through the motions, using the instruments and reproducing the sounds and pressure of the procedure without cutting away tissue. Neither the patients nor the staff who later scored their recovery knew who had received which. Building a genuine double-blind around an operation is demanding, which is part of why these trials carry so much weight.

Inside the FIDELITY trial#

The best-known of these studies is the Finnish FIDELITY trial, reported by Sihvonen and colleagues in the New England Journal of Medicine in 2013. It enrolled 146 adults aged 35 to 65 who had symptoms of a degenerative medial meniscus tear and, importantly, no osteoarthritis visible on imaging, the group orthopedic surgeons had long considered the best candidates for a trim.

A year on, both arms had improved substantially. Across the main symptom-and-function scores and on pain after exertion, the change from baseline to twelve months was statistically indistinguishable between the surgical group and the placebo group. The trimming had added nothing that the operating room theater and time had not already delivered.

The follow-up sealed it. When the same patients were reassessed five years later, in the British Journal of Sports Medicine in 2020, the two groups still reported comparable relief, and the surgical group actually showed a slightly higher rate of radiographic osteoarthritis progression, with no counterbalancing gain in how patients said their knees felt or worked. A procedure that fails to beat placebo, and that may nudge the joint toward more visible wear, is a poor trade.

Does one trial travel?#

A single elegant trial always invites the worry that its result is a local fluke. The answer here came from pooling. A 2023 individual-participant-data meta-analysis in Osteoarthritis and Cartilage assembled 605 randomized patients with MRI-confirmed degenerative meniscus tears from several trials and compared arthroscopic partial meniscectomy against non-surgical or sham care. Working from each patient's own record, rather than from published averages, gives a more faithful combined estimate and lets the analysts check whether particular subgroups behaved differently. They did not. Pain, knee function, and quality of life landed in the same place regardless of which treatment a patient had received. When a rigorous sham trial and a broad pooled analysis point the same way, a startling single finding hardens into a settled reading.

Reading any operation like a skeptic#

The meniscus case is worth remembering because the reasoning transfers to almost any procedure you are offered. A few questions do most of the work.

What was the surgery compared against? "Patients felt better afterward" is a description, not proof of cause. The informative comparison is against the best alternative, and where it can be managed, against a sham, so that the ceremony surrounding the operation is held equal on both sides.

What would the condition have done on its own? Anything that fluctuates or tends to settle over time will flatter almost any intervention when there is no control group. Degenerative knee pain often eases over months no matter what is done to it.

Is the scan the culprit or a bystander? A finding on imaging is not automatically the source of a symptom, especially when the same finding is common in people with no complaints. Treating the picture instead of the patient is a recurring mistake.

Were the assessors blinded, and was follow-up long enough? Blinded scoring protects against hopeful measurement, and a longer horizon catches harms and relapses a brief study would miss. FIDELITY earns its place in the teaching canon precisely because it did both.